For decades, thousands of people have been dying from malaria infections because of poor-
quality medicines (PQMs). While numerous efforts have been initiated to reduce their …

Malaria is a life-threatening disease being treated by oral medication. This is the best
treatment to reduce morbidity and mortality, prevent disease progression to the most severe …

Artemether–lumefantrine is the most widely used artemisinin-based combination therapy for
malaria. The present work aims to develop and validate a simple, accurate, precise and …

Cerebral malaria (CM), a severe neurological pathology caused by Plasmodium falciparum
infection, poses a significant global health threat and has a high mortality rate. Conventional …

The simple, accurate and precise UV-Spectrophotometric method has been developed and
validated for quantitative determination of artemether in capsules. The method employed lN …

New antimalarial tranquilize investigates are concentrating on promising focuses so as to
grow new medication competitors. Essential digestion and biochemical procedure in the …

Malaria remains a major tropical health burden owing to the development of resistance and
decreased sensitivity to the frequently used conventional antimalarial drugs. The drug like …

This paper describes the development and validation of a high performance liquid
chromatography (HPLCUV) method for the simultaneous quantitative determination of …

Current research work describes rapid reverse phase high performance chromatographic
method for estimation of dihydroartimisinine derivative namely arteether and artemether …

Lumefantrine is an antimalarial agent used to treat acute uncomplicated malaria. It is
administered in combination with artemether for improved efficacy. This combination therapy …